Cargando…
Cholesterol-lowering drugs reduce APP processing to Aβ by inducing APP dimerization
Amyloid beta (Aβ) is a major component of amyloid plaques, which are a key pathological hallmark found in the brains of Alzheimer’s disease (AD) patients. We show that statins are effective at reducing Aβ in human neurons from nondemented control subjects, as well as subjects with familial AD and sp...
Autores principales: | Langness, Vanessa F., van der Kant, Rik, Das, Utpal, Wang, Louie, Chaves, Rodrigo dos Santos, Goldstein, Lawrence S. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Cell Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098827/ https://www.ncbi.nlm.nih.gov/pubmed/33296223 http://dx.doi.org/10.1091/mbc.E20-05-0345 |
Ejemplares similares
-
APP dimer formation is initiated in the endoplasmic reticulum and differs between APP isoforms
por: Isbert, Simone, et al.
Publicado: (2011) -
Altering APP Proteolysis: Increasing sAPPalpha Production by Targeting Dimerization of the APP Ectodomain
por: Libeu, Clare A. Peters, et al.
Publicado: (2012) -
Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons
por: van der Kant, Rik, et al.
Publicado: (2019) -
Palmitoylated APP Forms Dimers, Cleaved by BACE1
por: Bhattacharyya, Raja, et al.
Publicado: (2016) -
Structural aspects and physiological consequences of APP/APLP trans-dimerization
por: Baumkötter, Frederik, et al.
Publicado: (2011)